Targeting Cystic Fibrosis Using a Novel Inhalation Therapy

使用新型吸入疗法治疗囊性纤维化

• 批准号: nhmrc : GNT1121694
• 负责人: Prof Daniela Traini
• 金额: $ 42.15万
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/targeting-cystic-fibrosis-inhalation-therapy/1347218
• 关键词: Targeting; Cystic; Fibrosis; Using; Novel

Currently treatments for cystic fibrosis infection are via oral, intravenous or lengthy inhalation processes. This can lead to significant side effects, consequent poor patient compliance, and limited therapeutic efficacy. We will develop and test a novel high-dose inhalation dry power device containing an antibiotics for the rapid treatment of infection in cystic fibrosis therapy.

目前囊性纤维化感染的治疗是通过口服、静脉注射或长时间吸入过程。这可能导致显着的副作用、患者依从性差以及治疗效果有限。我们将开发和测试一种新型高剂量吸入干动力装置，其中含有抗生素，用于快速治疗囊性纤维化治疗中的感染。